Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Prof Mark McCarthy who has won the 2016 Jacobæus Prize, in recognition of his outstanding contribution to the field of type 2 diabetes genetics. Prof McCarthy has played a central role in the discovery of type 2 diabetes ‘risk genes’ – both as a basic researcher and as a leading figure in international consortia.

Logo of Novo Nordisk (University of Oxford).

Talking about his work, Prof McCarthy said, “For about one third of the 100 DNA sequences associated with the risk of developing diabetes, we have achieved some understanding of the disturbances they cause in cells and organs. But we are striving to fully reconstruct the complete network of genetic risk and its consequences, and there is still much work to be done.” Prof McCarthy hopes that this research will contribute to improving the prospects of developing diagnostic tests and medicine.

The Jacobæus Prize is awarded annually by the Novo Nordisk Foundation and celebrates excellence in physiology and endocrinology. Prof McCarthy will be giving the key note lecture, entitled "Genomics of Diabetes - What's Next?" at the annual award ceremony on 18 May in Bergen.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Awards Department General IMD MRC HIU MRC WIMM

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Department General MRC MHU MRC WIMM NDCLS OCH Publication Research

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.

MRC HIU appoints new Director

Department General MRC HIU MRC WIMM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.